,
Dépret, François
Amzallag, Juliette
Pollina, Adrien
Fayolle-Pivot, Laure
Coutrot, Maxime
Chaussard, Maïté
Santos, Karine
Hartmann, Oliver
Jully, Marion
Fratani, Alexandre
Oueslati, Haikel
Cupaciu, Alexandru
Benyamina, Mourad
Guillemet, Lucie
Deniau, Benjamin
Mebazaa, Alexandre
Gayat, Etienne
Farny, Boris
Textoris, Julien
Legrand, Matthieu
Funding for this research was provided by:
Union des Blessés de la Face et de la Tête (2012)
Article History
Received: 20 February 2020
Accepted: 13 April 2020
First Online: 22 April 2020
Ethics approval and consent to participate
: The study protocol was approved by our local research ethical committee (Comité de Protection des Personnes 2013/17NICB).
: Not applicable.
: FD has received research grants from the French ministry of health, Société française d’anesthésie reanimation, European Society of Intensive Care Medicine, and lecture fees Sedana medical.JA has no conflict of interest.MCo has no conflict of interest.MCh has no conflict of interest.KS and OH are employed by 4TEEN4 Pharmaceuticals GmbH, a company which holds patent rights in and commercializes the DPP3 assay.MJ has no conflict of interest.AF has no conflict of interest.HO has no conflict of interest.AC has no conflict of interest.MB has no conflict of interest.LG has no conflict of interest.BD received research grant from 4TEEN4 Pharmaceuticals GmbH.AM has received speaker’s honoraria from Novartis, Orion, and Servier and fees as a member of the advisory board and/or steering committee from Cardiorentis, Adrenomed, sphingotec, Sanofi, Roche, Abbott, and Bristol-Myers Squibb.BS has no conflict of interest.JT is employed by Biomerieux.ML has received research grants from the French ministry of health, lecture fees from Baxter, and Fresenius and research support from Sphingotec.